On the public citation graph
Efficacy and safety of rituximab in autoimmune encephalitis: A meta‐analysis
0 signed · 126 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jamaneurol.2016.1637openalex-snapshot
Efficacy and Safety of Rituximab Therapy in Neuromyelitis Optica Spectrum Disorders
inferredcites →https://doi.org/10.1007/s00415-015-7781-9openalex-snapshot
Treatment and outcome of children and adolescents with N-methyl-d-aspartate receptor encephalitis
inferredcites →https://doi.org/10.1007/s00415-019-09607-3openalex-snapshot
Diagnosing autoimmune encephalitis in a real-world single-centre setting
inferredcites →https://doi.org/10.1007/s10072-018-3648-zopenalex-snapshot
Clinical variability of children with anti-N-methyl-d-aspartate receptor encephalitis in southern Brazil: a cases series and review of the literature
inferredcites →https://doi.org/10.1007/s13311-016-0442-6openalex-snapshot
Tocilizumab in Autoimmune Encephalitis Refractory to Rituximab: An Institutional Cohort Study
inferredcites →https://doi.org/10.1016/j.autrev.2019.03.011openalex-snapshot
Efficacy and safety of rituximab for relapsing-remitting multiple sclerosis: A systematic review and meta-analysis
inferredcites →https://doi.org/10.1016/j.braindev.2018.02.005openalex-snapshot
Anti-N-methyl-d-aspartate receptor encephalitis in children: Incidence and experience in Hong Kong
inferredcites →https://doi.org/10.1016/j.ctrv.2016.11.015openalex-snapshot
Rituximab: 13 open questions after 20years of clinical use
inferredcites →https://doi.org/10.1016/j.jclinepi.2009.06.006openalex-snapshot
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
inferredcites →https://doi.org/10.1016/j.jneuroim.2019.02.008openalex-snapshot
Reduced dosage rituximab in the treatment of anti-N-methyl-d-aspartate receptor encephalitis: An observation study in Chinese patients
inferredcites →https://doi.org/10.1016/j.jns.2017.04.007openalex-snapshot
Lower dosages of rituximab used successfully in the treatment of anti-NMDA receptor encephalitis without tumour
inferredcites →https://doi.org/10.1016/j.jns.2017.08.2561openalex-snapshot
Rituximab therapy and clinical management in anti-NMDA receptor antibody encephalitis refractory to first-line immunotherapy: Japanese case series
inferredcites →https://doi.org/10.1016/j.jpeds.2006.10.067openalex-snapshot
Clinical Effects and Safety of Rituximab for Treatment of Refractory Pediatric Autoimmune Diseases
inferredcites →https://doi.org/10.1016/j.pedneo.2018.10.006openalex-snapshot
Immunotherapy for anti-NMDA receptor encephalitis: Experience from a single center in Taiwan
inferredcites →https://doi.org/10.1016/s1474-4422(12)70310-1openalex-snapshot
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
inferredcites →https://doi.org/10.1164/rccm.201603-0507ocopenalex-snapshot
Anti– N -Methyl- d -Aspartate Receptor Encephalitis in Adult Patients Requiring Intensive Care
inferredcites →https://doi.org/10.1177/1756285609356135openalex-snapshot
Practical considerations on the use of rituximab in autoimmune neurological disorders
inferredcites →https://doi.org/10.1177/1756285617722347openalex-snapshot
Treatment strategies for autoimmune encephalitis
inferredcites →https://doi.org/10.1186/1471-2288-14-135openalex-snapshot
Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
inferredcites →https://doi.org/10.1186/1757-1626-2-1openalex-snapshot
Stent angioplasty of narrowed portocaval shunt in Budd Chiari syndrome: a case report
inferredcites →https://doi.org/10.1186/s12883-019-1261-2openalex-snapshot
Effectiveness of rituximab in neuromyelitis optica: a meta-analysis
inferredcites →https://doi.org/10.1212/nxi.0000000000000663openalex-snapshot
Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient
inferredcites →https://doi.org/10.1212/wnl.0000000000000570openalex-snapshot
Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease
inferredcites →https://doi.org/10.1212/wnl.0000000000002635openalex-snapshot
Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort
inferredcites →https://doi.org/10.1371/journal.pmed.1000100openalex-snapshot
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
inferredcites →https://doi.org/10.1371/journal.pone.0146455openalex-snapshot
Effect of Immunotherapy on Seizure Outcome in Patients with Autoimmune Encephalitis: A Prospective Observational Registry Study
inferredcites →https://doi.org/10.14581/jer.16010openalex-snapshot
The Laboratory Diagnosis of Autoimmune Encephalitis
inferredcites →https://doi.org/10.2147/dddt.s139248openalex-snapshot
Current perspective on rituximab in rheumatic diseases
inferredcites →https://doi.org/10.2217/fnl-2019-0026openalex-snapshot
Open Issues in Antibody-Mediated Encephalitis
inferredcites →https://doi.org/10.3389/fimmu.2019.01990openalex-snapshot
Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders
inferredcites →https://doi.org/10.3389/fneur.2015.00163openalex-snapshot
CD8+ T Cell-Mediated Neuronal Dysfunction and Degeneration in Limbic Encephalitis
inferredcites →https://doi.org/10.3389/fneur.2019.00080openalex-snapshot
Detection of Children/Youth With Fetal Alcohol Spectrum Disorder Through Eye Movement, Psychometric, and Neuroimaging Data
inferredcites →https://doi.org/10.3389/fneur.2019.00906openalex-snapshot
Pediatric Autoimmune Encephalitis: Case Series From Two Chinese Tertiary Pediatric Neurology Centers
inferredcites →https://doi.org/10.3760/cma.j.issn.0578-1310.2017.09.013openalex-snapshot
[Effectiveness and safety of rituximab for children with autoimmune diseases of the nervous system].
inferredcites →https://doi.org/10.3988/jcn.2016.12.1.1openalex-snapshot
The Diagnosis and Treatment of Autoimmune Encephalitis
inferredcites →https://doi.org/10.4076/1757-1626-2-6609openalex-snapshot
Rituximab for the treatment of refractory pediatric autoimmune diseases: a case series
inferredcites →https://doi.org/10.4103/aian.aian_499_16openalex-snapshot
Rituximab in neuromyelitis optica spectrum disorders: Our experience
inferredcites →https://doi.org/10.7326/0003-4819-151-4-200908180-00136openalex-snapshot
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4829109openalex-extracted
The Therapeutic Effect of Ofatumumab in Pediatric Anti-Nmdar Encephalitis: A Case Series
inferred← citeshttps://doi.org/10.1002/14651858.cd013874openalex-snapshot
Rituximab for people with multiple sclerosis
inferred← citeshttps://doi.org/10.1002/14651858.cd013874.pub2openalex-snapshot
Rituximab for people with multiple sclerosis
inferred← citeshttps://doi.org/10.1002/ana.27218openalex-snapshot
Efficacy and Safety of Ofatumumab Treatment for Anti‐ NMDA Receptor Autoimmune Encephalitis ( OFF ‐ AE ): A Prospective, Multicenter Cohort Study
inferred← citeshttps://doi.org/10.1002/brb3.1793openalex-snapshot
Anti‐LGI1, anti‐GABABR, and Anti‐CASPR2 encephalitides in Asia: A systematic review
inferred← citeshttps://doi.org/10.1002/jca.22112openalex-snapshot
Suspected autoimmune encephalitis: A retrospective study of patients referred for therapeutic plasma exchange
inferred← citeshttps://doi.org/10.1002/nep3.70063openalex-snapshot
Effectiveness and safety of efgartigimod in patients with anti‐NMDAR or anti‐LGI1 encephalitis and its 18 F‐DPA714 PET imaging evaluation: A multicenter, single‐arm, prospective, observational real‐world study
inferred← citeshttps://doi.org/10.1007/s00415-025-13485-3openalex-snapshot
Efgartigimod-rituximab sequential therapy in Anti-NMDAR encephalitis: real-world evidence for a novel salvage-maintenance strategy
inferred← citeshttps://doi.org/10.1007/s10072-022-06313-3openalex-snapshot
Intravenous immunoglobulin bridging to rituximab in NMDAR encephalitis patients non-responders to first-line treatments
inferred← citeshttps://doi.org/10.1007/s10072-024-07876-zopenalex-snapshot
Efficacy of ofatumumab combined with corticosteroids in the treatment of autoimmune encephalitis: a 6-month cohort study
inferred← citeshttps://doi.org/10.1007/s10072-025-08210-xopenalex-snapshot
Risk factors for poor response to initial first-line immunotherapy and subsequent immunotherapy on prognosis in pediatric anti-NMDA receptor encephalitis
inferred← citeshttps://doi.org/10.1007/s10072-025-08228-1openalex-snapshot
Low-dose rituximab for the treatment of anti-NMDAR encephalitis in children: a case series study
inferred← citeshttps://doi.org/10.1007/s13311-020-00921-7openalex-snapshot
Teratoma Removal, Steroid, IVIG, Rituximab and Tocilizumab (T-SIRT) in Anti-NMDAR Encephalitis
inferred← citeshttps://doi.org/10.1007/s13311-021-01178-4openalex-snapshot
Antibody Therapies in Autoimmune Encephalitis
inferred← citeshttps://doi.org/10.1007/s13760-022-02124-7openalex-snapshot
Anti-contactin-associated protein-like 2 antibody autoimmune encephalitis with rapidly progressive parkinsonism: a case report and literature review
inferred← citeshttps://doi.org/10.1007/s13760-023-02174-5openalex-snapshot
Contactin-associated protein-like 2 antibody-associated autoimmune encephalitis in children: case reports and systematic review of literature
inferred← citeshttps://doi.org/10.1007/s40120-026-01048-1openalex-snapshot
Optimizing the Use of Anti-CD20 Agents in Multiple Sclerosis and Other Autoimmune Central Nervous System Disorders: A Narrative Review
inferred← citeshttps://doi.org/10.1007/s40618-024-02370-xopenalex-snapshot
CD20 + T lymphocytes in isolated Hashimoto’s thyroiditis and type 3 autoimmune polyendocrine syndrome: a pilot study
inferred← citeshttps://doi.org/10.1016/b978-0-12-824060-1.00028-6openalex-snapshot
Innovative therapies
inferred← citeshttps://doi.org/10.1016/b978-0-323-90887-0.00004-3openalex-snapshot
Immunotherapies on autoimmune encephalitis
inferred← citeshttps://doi.org/10.1016/b978-0-443-19200-5.00012-9openalex-snapshot
Clinical efficacy of anti-CD20 antibodies in neurological and neuromuscular diseases
inferred← citeshttps://doi.org/10.1016/j.bbih.2026.101270openalex-snapshot
Th1/Th17-linked transcription factors TBX21 and RORC were associated with clinical response to rituximab in treatment-resistant schizophrenia
inferred← citeshttps://doi.org/10.1016/j.biopha.2025.118669openalex-snapshot
Neurologic complications of immune checkpoint inhibitors: A comprehensive review
inferred← citeshttps://doi.org/10.1016/j.clineuro.2026.109604openalex-snapshot
Different oral prednisone tapering regimens for the treatment of anti-LGI1 encephalitis: A multicenter cohort study
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e28171openalex-snapshot
Nanocarrier-mediated cancer therapy with cisplatin: A meta-analysis with a promising new paradigm
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e40680openalex-snapshot
The therapeutic effect of ofatumumab in pediatric anti-NMDAR encephalitis: A case series
inferred← citeshttps://doi.org/10.1016/j.heliyon.2025.e41747openalex-snapshot
Efficacy of rituximab as second-line therapy for autoimmune encephalitis: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.intimp.2021.107565openalex-snapshot
The clinical efficacy of Rituximab administration in autoimmunity disorders, primary immunodeficiency diseases and malignancies
inferred← citeshttps://doi.org/10.1016/j.jneuroim.2022.577812openalex-snapshot
Safety and efficacy of rituximab for relapse prevention in myelin oligodendrocyte glycoprotein immunoglobulin G (MOG-IgG)-associated disorders (MOGAD): A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.jneuroim.2024.578458openalex-snapshot
Ofatumumab treatment for severe refractory anti-NMDAR encephalitis: A case series
inferred← citeshttps://doi.org/10.1016/j.jneuroim.2025.578835openalex-snapshot
Personalized Ofatumumab therapy for autoimmune encephalitis: A case series of four patients
inferred← citeshttps://doi.org/10.1016/j.msard.2026.107158openalex-snapshot
Ocular toxicity associated with anti-CD20 monoclonal antibodies: A pharmacovigilance analysis using the FAERS database
inferred← citeshttps://doi.org/10.1016/j.neurol.2021.12.001openalex-snapshot
Immunomodulation in the acute phase of autoimmune encephalitis
inferred← citeshttps://doi.org/10.1016/j.neurol.2024.07.002openalex-snapshot
The immunology underlying CNS autoantibody diseases
inferred← citeshttps://doi.org/10.1016/j.neurot.2025.e00766openalex-snapshot
Effectiveness of Anti-CD20 B cells depleting therapy versus conventional treatment in severe Anti-N-methyl-d-aspartate receptor encephalitis: A real-world multi-center prospective cohort study
inferred← citeshttps://doi.org/10.1016/j.pccm.2023.08.002openalex-snapshot
Pathogenesis, pathological characteristics and individualized therapy for immune-related adverse effects
inferred← citeshttps://doi.org/10.1016/j.pediatrneurol.2022.05.004openalex-snapshot
Autoimmune Encephalitis in Children
inferred← citeshttps://doi.org/10.1016/j.pediatrneurol.2025.09.012openalex-snapshot
Rituximab for Anti-N-Methyl-D-Aspartate Receptor Encephalitis in Children: How Safe and Effective Is It?
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2022.108180openalex-snapshot
Distinct mechanisms underlying therapeutic potentials of CD20 in neurological and neuromuscular disease
inferred← citeshttps://doi.org/10.1016/j.smim.2025.101955openalex-snapshot
From immunobiology to intervention: Pathophysiology of autoimmune encephalitis
inferred← citeshttps://doi.org/10.1016/j.yebeh.2025.110280openalex-snapshot
Use of intrathecal rituximab in autoimmune epilepsy: A retrospective study
inferred← citeshttps://doi.org/10.1017/9781108539623.006openalex-snapshot
The Role of Autoimmune Encephalitis in Immunopsychiatry and Lessons from Neuropsychiatric Systemic Lupus Erythematosus
inferred← citeshttps://doi.org/10.1055/a-1400-8393openalex-snapshot
Psychiatrische Autoimmunenzephalitis – Diagnose und therapeutische Ansätze
inferred← citeshttps://doi.org/10.1055/s-0044-1788586openalex-snapshot
Brazilian consensus recommendations on the diagnosis and treatment of autoimmune encephalitis in the adult and pediatric populations
inferred← citeshttps://doi.org/10.1080/14740338.2024.2446425openalex-snapshot
Pharmacologically induced autoimmune encephalitis—disproportionality analysis utilizing FAERS database
inferred← citeshttps://doi.org/10.1093/bjd/ljac118openalex-snapshot
Risk of infections in patients with pemphigus treated with rituximab vs. azathioprine or mycophenolate mofetil: a large-scale global cohort study
inferred← citeshttps://doi.org/10.1093/jalm/jfab102openalex-snapshot
Autoimmune Encephalitis and Autoantibodies: A Review of Clinical Implications
inferred← citeshttps://doi.org/10.1097/wco.0000000000000909openalex-snapshot
Management of autoimmune encephalitis
inferred← citeshttps://doi.org/10.1111/cns.14416openalex-snapshot
Ofatumumab for the treatment of refractory anti‐LGI1 encephalitis with long‐term poor blood glucose control in type 1 diabetes
inferred← citeshttps://doi.org/10.1111/epi.17327openalex-snapshot
Second‐line immunotherapy and functional outcomes in autoimmune encephalitis: A systematic review and individual patient data meta‐analysis
inferred← citeshttps://doi.org/10.1136/bcr-2022-253835openalex-snapshot
Rituximab for treatment of pachymeningitis in granulomatosis with polyangiitis
inferred← citeshttps://doi.org/10.1155/ane/1934971openalex-snapshot
Challenges in Access to Diagnosis and Treatment of Autoimmune Encephalitis in Hospitals in Latin America and the Caribbean
inferred← citeshttps://doi.org/10.1155/carm/4810248openalex-snapshot
Encephalitis and Immune‐Related Complications in a Patient Treated With Nivolumab: A Case Report
inferred← citeshttps://doi.org/10.1177/17562864211054157openalex-snapshot
Efficacy and safety of immunosuppressive therapy in myelin oligodendrocyte glycoprotein antibody–associated disease: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1177/1756286421998906openalex-snapshot
Autoimmune encephalopathies presenting as dementia of subacute onset and rapid progression
inferred← citeshttps://doi.org/10.1212/con.0000000000001463openalex-snapshot
Therapeutic Approach to Autoimmune Neurologic Disorders
inferred← citeshttps://doi.org/10.1212/nxi.0000000000001088openalex-snapshot
Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis
inferred← citeshttps://doi.org/10.12890/2024_004572openalex-snapshot
Anti-LGI1 autoimmune encephalitis in a patient with rheumatoid arthritis and MGUS
inferred← citeshttps://doi.org/10.18705/2782-3806-2024-4-4-319-328openalex-snapshot
The experience of anti-b-cell therapy with rituximab in children with chronic inflammatory demyelinating polyradiculoneuropathy with a description of the clinical case
inferred← citeshttps://doi.org/10.2174/1381612828666220131093259openalex-snapshot
Diagnostic Approach and Treatment Regimens in Adult Patients Suffering from Antibody- mediated or Paraneoplastic Encephalitis
inferred← citeshttps://doi.org/10.2174/1570159x20666220706102708openalex-snapshot
Epilepsy and Cognitive Impairment in Childhood and Adolescence: A Mini-Review
inferred← citeshttps://doi.org/10.22141/2224-0713.17.5.2021.238518openalex-snapshot
Efficacy of rituximab in autism spectrum disorders associated with hereditary folate malabsorption with signs of antineuronal autoimmunity
inferred← citeshttps://doi.org/10.32345/2664-4738.3.2021.03openalex-snapshot
THE RESULTS OF THE SEARCH FOR LABORATORY SIGNS OF AUTOIMMUNE REACTIONS TO CEREBRAL AND EXTRACEREBRAL AUTOANTIGENS IN CHILDREN WITH AUTISM SPECTRUM DISORDERS ASSOCIATED WITH GENETIC DEFICIENCY OF THE FOLATE CYCLE
inferred← citeshttps://doi.org/10.3389/fimmu.2021.790962openalex-snapshot
Immunotherapy for Refractory Autoimmune Encephalitis
inferred← citeshttps://doi.org/10.3389/fimmu.2022.890656openalex-snapshot
Clinical Features, Treatment, and Prognostic Factors in Neuronal Surface Antibody-Mediated Severe Autoimmune Encephalitis
inferred← citeshttps://doi.org/10.3389/fimmu.2023.1213532openalex-snapshot
Clinical characteristics and prognosis in patients with neuronal surface antibody-mediated autoimmune encephalitis: a single-center cohort study in China
inferred← citeshttps://doi.org/10.3389/fimmu.2024.1368275openalex-snapshot
B-cell targeted therapies in autoimmune encephalitis: mechanisms, clinical applications, and therapeutic potential
inferred← citeshttps://doi.org/10.3389/fimmu.2025.1640790openalex-snapshot
Telitacicept as a novel B cell-targeted therapy in autoimmune encephalitis: a case report
inferred← citeshttps://doi.org/10.3389/fimmu.2026.1837836openalex-snapshot
Immunopathological mechanisms in autoimmune encephalitis: from pathogenesis to targeted therapies
inferred← citeshttps://doi.org/10.3389/fimmu.2026.1896060openalex-snapshot
Research progress on the association between Hashimoto’s thyroiditis and autoimmune encephalitis: a review
inferred← citeshttps://doi.org/10.3389/fneur.2020.606923openalex-snapshot
Efficacy and Safety of Rituximab in Chinese Children With Refractory Anti-NMDAR Encephalitis
inferred← citeshttps://doi.org/10.3389/fneur.2021.736190openalex-snapshot
Effectiveness and Safety of Rituximab for Refractory Myasthenia Gravis: A Systematic Review and Single-Arm Meta-Analysis
inferred← citeshttps://doi.org/10.3389/fneur.2021.791014openalex-snapshot
Clinical Features and Therapeutic Effects of Anti-leucine-rich Glioma Inactivated 1 Encephalitis: A Systematic Review
inferred← citeshttps://doi.org/10.3389/fneur.2022.741244openalex-snapshot
Targeting Inflammatory Mediators in Epilepsy: A Systematic Review of Its Molecular Basis and Clinical Applications
inferred← citeshttps://doi.org/10.3389/fneur.2022.949240openalex-snapshot
Long-term-video monitoring EEG and 18F-FDG-PET are useful tools to detect residual disease activity in anti-LGI1-Abs encephalitis: A case report
inferred← citeshttps://doi.org/10.3389/fneur.2023.1275533openalex-snapshot
Rituximab treatment in myasthenia gravis
inferred← citeshttps://doi.org/10.37321/ujmh.2021.1-2-04openalex-snapshot
РЕЗУЛЬТАТИ ВИВЧЕННЯ МІКРОБНОГО СПЕКТРУ У ДІТЕЙ З РОЗЛАДАМИ СПЕКТРУ АУТИЗМУ, АСОЦІЙОВАНИМИ З ГЕНЕТИЧНИМ ДЕФІЦИТОМ ФОЛАТНОГО ЦИКЛУ
inferred← citeshttps://doi.org/10.47162/rjme.64.4.03openalex-snapshot
Autoimmune encephalitis and paraneoplastic encephalitis: difficulties in diagnosis and management in the ICU
inferred← citeshttps://doi.org/10.5005/jaopn-11028-0021openalex-snapshot
A Baby with Acute Encephalopathy, Refractory Hyponatremia, and Hypertension: A Case Report
inferred← citeshttps://doi.org/10.5772/intechopen.1012064openalex-snapshot
Autoimmune Encephalitis: Diagnosis, Treatment, and Subtypes
inferred← citeshttps://doi.org/10.70322/immune.2025.10008openalex-snapshot
The Immunopathogenesis of Autoimmune Encephalitis-Related Psychosis, A Comprehensive Review of Humoral and Cellular Mechanisms
inferred← citeshttps://doi.org/10.7196/samj.2023.v113i4.875openalex-snapshot
Autoimmune encephalitis: Epidemiology, pathophysiology and clinical spectrum (part 2)
inferred← citeshttps://doi.org/10.7499/j.issn.1008-8830.2204021openalex-snapshot
Recent research on immunotherapy for anti-N-methyl-D-aspartate receptor encephalitis.
inferred← citeshttps://doi.org/10.7759/cureus.62227openalex-snapshot
Rituximab Therapy for Immune-Mediated Neurological Diseases: Our Experience at a Tertiary Care Centre
inferred← citeshttps://doi.org/10.7759/cureus.82062openalex-snapshot
Decoding Autoimmunity: Insights Into Neuromyelitis Optica and Its Relationship With Other Autoimmune Neurological Disorders
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.